Fraunhofer Institute for Cell Therapy and Immunology IZI

Minimal operation at Fraunhofer IZI

Minimal operation at Fraunhofer IZI

Dear Sir or Madam,

due to the corona pandemic, the Fraunhofer Institute for Cell Therapy and Immunology has reduced research operations to a necessary minimum. Since March 19, 2020, a large part of the staff has therefore been working from home and cannot be reached on site or by telephone.

Please use preferably emails to contact us.

If you have a particularly urgent request and cannot reach any of your contacts via email, please send an email to: jens.augustin@izi.fraunhofer.de

We will try to process your request as soon as possible.

Many thanks for your understanding.

 

Translated with www.DeepL.com/Translator (free version)

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products for the business units Cell and Gene Therapy, Drugs and Diagnostics. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. The research focus is on developments in the field of immunoncology and infection research.

The institute works in close cooperation with hospital institutions and performs quality tests besides carrying out the GMP-compliant manufacture of clinical test samples. Furthermore, it helps partners obtain manufacturing licenses and permits.

Business units

Jobs / career

Press

Publications

Research projects funded by the EU

News

 

Press release / 2.3.2020

Hitchhiker’s Guide to the Cell: Fraunhofer IZI researches to improve imaging methods for organoids

On 1st March 2020, a new research project was launched at the Fraunhofer IZI. Imaging of living cells is to be improved by means of viral and bacterial targeting sequences. The project is supported by the Volkswagen Foundation ...

Press release PIONEER Consortium / 26.2.2020

Significant PIONEER milestone – First two datasets uploaded into the PIONEER Big Data platform

PIONEER is a European Network of Excellence for Big Data in Prostate Cancer, consisting of 32 partners across 9 countries, among them Fraunhofer IZI. In an important step forward the first datasets have been transferred into the PIONEER Big Data platform by PIONEER partner Erasmus University Medical Centre (MC). Through the application of Big Data and the analyses of real-world evidence PIONEER aims to change the prostate cancer landscape to improve the health and social care received by all prostate cancer patients and their families. Fraunhofer IZI works in the framework of the PIONEER project on the topics data harmonisation of transcriptome-wide expression studies as well as statistical data analyses to identify and confirm biomarkers.

Press release / 20.12.2019

Development of therapeutic antibodies for HERV-associated autoimmune and tumor diseases

Human endogenous retroviruses (HERVs) and, more specifically, their envelope proteins are suspected of transporting diseases such as multiple sclerosis, rheumatism and tumor diseases. A joint research project between the Fraunhofer IZI and Halle University Hospital is expected to deliver new insights based on the characterization of HERV envelope proteins. The aim is to develop therapeutic antibodies for HERV-associated autoimmune and tumor diseases ...

 

Press release / 3.12.2019

Making novel therapeutics safer

Fraunhofer IZI takes lead on EU project developing highly innovative model systems to evaluate immunomodulatory therapeutic agents. The development of immunomodulatory agents and therapies has received fresh impetus following the latest successes in immuno-oncology. And cancer medicine is not the only area where cell and gene therapies are increasingly taking hold ...

Contact

Fraunhofer IZI

 

Perlickstraße 1
04103 Leipzig
Germany

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000
E-mail info@izi.fraunhofer.de

 

Social Media